戻る Agenda
Session 6: Risk Assessment of Identified Gaps
Session Chair(s)
Yvonne Ditoro, BSN, MBA, RN
Pharmacovigilance Operations Consultant
Yvonne Ditoro and Associates LLC, United States
- Identifying potential risks and determining if they are critical based on impact
- Review common pharmacovigilance inspection findings from FDA and MHRA